Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × HER2-positive Breast Cancer × pyrotinib × Clear all

Phase

Phase 2 8 Phase NA 1 Phase 4 1 Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 HER2-positive Breast Cancer 1 HER2 Positive Breast Cancer 1 Colorectal Neoplasms 1 Breast Neoplasm Female 1 Breast Diseases 1 Breast Cancer Female 1

Interventions

pyrotinib 1 pertuzumab 1 Trastuzumab 1 Isovaleryl-CoA Dehydrogenase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06718335 2024-12-11

Pyrotinib in HER2-positive Early Breast Cancer

Yunnan Cancer Hospital

Phase NA Not yet recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡